Lisata Therapeutics, Inc. has announced a significant corporate action: a one-for-fifteen reverse stock split, set to take effect on November 23, 2026. This decision, approved by the company's stockholders during the annual meeting on November 9, 2026, aims to enhance the company's stock price and improve its market perception.

The reverse stock split means that every fifteen shares of common stock will be combined into one share. This adjustment will not change the total number of authorized shares or the par value per share. However, it is expected to impact the trading dynamics of the stock, which trades under the symbol LSTA on the Nasdaq.

Background

Lisata Therapeutics, Inc., classified under the SIC code 2834 for Pharmaceutical Preparations, operates in the life sciences sector. The company has been actively filing various reports with the SEC, including a recent 10-Q on November 13, 2026, and an S-3 on November 12, 2026. The company is listed on the Nasdaq under the ticker LSTA.

What the Filing Says

According to the recent SEC filing (accession number 0001140361-26-044826), the reverse stock split will become effective at 12:01 a.m. Eastern Time on November 23, 2026. The filing states, "As a result of the reverse stock split, every fifteen shares of Common Stock issued and outstanding immediately before the Effective Time will be combined into one share of Common Stock." The filing also emphasizes that no fractional shares will be issued, and those entitled to fractional shares will receive a cash payment based on the closing price of the Common Stock on the date of the filing.

Impact

This corporate action may affect current shareholders, as their holdings will be consolidated. The move is designed to improve the company's stock price, potentially making it more attractive to institutional investors and analysts. The reverse stock split is often viewed as a strategy to boost a company's market image, especially in the competitive pharmaceutical sector.

What's Next

The filing does not specify any further actions following the reverse stock split, but it indicates that trading will commence on a split-adjusted basis on November 23, 2026. Investors and analysts will be watching closely to see how this change impacts the company's market performance and investor sentiment.